Year Book of Psychiatry and Applied Mental Health 2011

1. Cover - p. 1 2. Contents - p. 2 3. Sleep and the Transition to Adolescence: A Longitudinal Study - p. 8 4. The Stigma of Childhood Mental Disorders: A Conceptual Framework - p. 9 5. The Long War and Parental Combat Deployment: Effects on Military Children and At-Home Spouses - p. 10 6. Clinical, Demographic, and Familial Correlates of Bipolar Spectrum Disorders Among Offspring of Parents With Bipolar Disorder - p. 11 7. Streptococcal Upper Respiratory Tract Infections and Psychosocial Stress Predict Future Tic and Obsessive-Compulsive Symptom Severity in Children and Adolescents with Tourette Syndrome and Obsessive-Compulsive Disorder - p. 12 8. Early Risk Factors and Developmental Pathways to Chronic High Inhibition and Social Anxiety Disorder in Adolescence - p. 13 9. Neural Abnormalities in Early-Onset and Adolescence-Onset Conduct Disorder - p. 14 10. Decreased Hippocampal Volume in Healthy Girls at Risk of Depression - p. 15 11. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use - p. 16 12. The Association of Suicide and Bullying in Childhood to Young Adulthood: A Review of Cross–Sectional and Longitudinal Research Findings - p. 17 13. Basal Ganglia Shapes Predict Social, Communication, and Motor Dysfunctions in Boys With Autism Spectrum Disorder - p. 18 14. The Moderating Role of Close Friends in the Relationship Between Conduct Problems and Adolescent Substance Use - p. 19 15. Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study - p. 20 16. Policy Statement—Alcohol Use by Youth and Adolescents: A Pediatric Concern - p. 21 17. Prenatal Organochlorine Exposure and Behaviors Associated With Attention Deficit Hyperactivity Disorder in School-Aged Children - p. 22 18. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia - p. 23 19. Attention-Deficit/Hyperactivity Disorder and Urinary Metabolites of Organophosphate Pesticides - p. 24 20. Unraveling the Nature of Hyperactivity in Children With Attention-Deficit/Hyperactivity Disorder - p. 25 21. Prediction of Psychosis in Adolescents and Young Adults at High Risk: Results From the Prospective European Prediction of Psychosis Study - p. 26 22. Prevalence and Treatment of Mental Disorders Among US Children in the 2001–2004 NHANES - p. 27 23. National Comorbidity Survey Replication Adolescent Supplement (NCS-A): III. Concordance of DSM-IV/CIDI Diagnoses With Clinical Reassessments - p. 28 24. Posttraumatic growth and reduced suicidal ideation among adolescents at month 1 after the Sichuan Earthquake - p. 29 25. Trends in Antipsychotic Drug Use by Very Young, Privately Insured Children - p. 30 26. Psychiatric Disorders in Preschool Offspring of Parents With Bipolar Disorder: The Pittsburgh Bipolar Offspring Study (BIOS) - p. 31 27. The association of visuospatial working memory with dysthymic disorder in pre-pubertal children - p. 32 28. Mental Health Treatment Received by Youths in the Year Before and After a New Diagnosis of Bipolar Disorder - p. 33 29. Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, United States, 2006 - p. 34 30. Pediatric Bipolar Disorder Versus Severe Mood Dysregulation: Risk for Manic Episodes on Follow-Up - p. 35 31. Developmental dyslexia in Chinese and English populations: dissociating the effect of dyslexia from language differences - p. 36 32. A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder - p. 37 33. Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy - p. 38 34. Modeled Economic Evaluation of Alternative Strategies to Reduce Sudden Cardiac Death Among Children Treated for Attention Deficit/Hyperactivity Disorder - p. 39 35. Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts - p. 40 36. Impact of Childhood Trauma on Treatment Outcome in the Treatment for Adolescents with Depression Study (TADS) - p. 41 37. Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 Outcomes - p. 42 38. Psychiatric Symptoms Among Juveniles Incarcerated in Adult Prison - p. 43 39. Adolescent Prescription ADHD Medication Abuse Is Rising Along With Prescriptions for These Medications - p. 44 40. Adolescent Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder in a Diverse Community Sample - p. 45 41. Brief, Personality-Targeted Coping Skills Interventions and Survival as a Non–Drug User Over a 2-Year Period During Adolescence - p. 46 42. Serious Emotional Disturbance Among Youths Exposed to Hurricane Katrina 2 Years Postdisaster - p. 47 43. Association of Hospitalization for Infection in Childhood With Diagnosis of Autism Spectrum Disorders: A Danish Cohort Study - p. 48 44. Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism - p. 49 45. Effects of Catechol-O-Methyltransferase on Normal Variation in the Cognitive Function of Children - p. 50 46. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Posttraumatic Stress Disorder - p. 51 47. Chapter 2: Attachment-Based Family Therapy for Adolescents with Suicidal Ideation: A Randomized Controlled Trial - p. 52 48. Clinical Effectiveness of Individual Cognitive Behavioral Therapy for Depressed Older People in Primary Care: A Randomized Controlled Trial - p. 53 49. Changes in Self-Schema Structure in Cognitive Therapy for Major Depressive Disorder: A Randomized Clinical Trial - p. 54 50. Mindfulness-Based Cognitive Therapy for Individuals Whose Lives Have Been Affected by Cancer: A Randomized Controlled Trial - p. 55 51. Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial - p. 56 52. Short-Term Psychodynamic Psychotherapy and Cognitive-Behavioral Therapy in Generalized Anxiety Disorder: A Randomized, Controlled Trial - p. 57 53. Clinical effectiveness of online computerised cognitive–behavioural therapy without support for depression in primary care: randomised trial - p. 58 54. Childhood Sexual Abuse Differentially Predicts Outcome of Cognitive-Behavioral Therapy for Deliberate Self-Harm - p. 59 55. What Are the Components of CBT for Psychosis? A Delphi Study - p. 60 56. Patient Personality and Outcome in Short-Term Psychodynamic Psychotherapy - p. 61 57. Disparity in Use of Psychotherapy Offered in Primary Care Between Older African-American and White Adults: Results from a Practice-Based Depression Intervention Trial - p. 62 58. Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic Depression: The REVAMP Trial - p. 63 59. Women With Bulimic Eating Disorders: When Do They Receive Treatment for an Eating Problem? - p. 64 60. Psychological Treatments of Binge Eating Disorder - p. 65 61. A Community-Based Treatment for Native American Historical Trauma: Prospects for Evidence-Based Practice - p. 66 62. Racial and Ethnic Disparities in Use of Psychotherapy: Evidence From U.S. National Survey Data - p. 67 63. Changing Network Support for Drinking: Network Support Project 2-Year Follow-Up - p. 68 64. Partner Violence Before and After Couples-Based Alcoholism Treatment for Female Alcoholic Patients - p. 69 65. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people - p. 70 66. Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study - p. 71 67. Multisystemic Therapy for Adolescents With Poorly Controlled Type 1 Diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months - p. 72 68. Group-Based Randomized Trial of Contingencies for Health and Abstinence in HIV Patients - p. 73 69. Testing the Efficacy of Theoretically Derived Improvements in the Treatment of Social Phobia - p. 74 70. Expressive Writing for Gay-Related Stress: Psychosocial Benefits and Mechanisms Underlying Improvement - p. 75 71. Specific Personality Traits Evoke Different Countertransference Reactions: An Empirical Study - p. 76 72. Cost-effectiveness of psychotherapy for cluster B personality disorders - p. 77 73. Cognitive–Behavioral Therapy Versus Usual Clinical Care for Youth Depression: An Initial Test of Transportability to Community Clinics and Clinicians - p. 78 74. Battlemind Debriefing and Battlemind Training as Early Interventions With Soldiers Returning From Iraq: Randomization by Platoon - p. 79 75. The Impact of Narcissism on Drop-Out From Cognitive–Behavioral Therapy for the Eating Disorders: A Pilot Study - p. 80 76. Unique and Common Mechanisms of Change Across Cognitive and Dynamic Psychotherapies - p. 81 77. Expressed Emotion Moderates the Effects of Family-Focused Treatment for Bipolar Adolescents - p. 82 78. Personality, Stressful Life Events, and Treatment Response in Major Depression - p. 83 79. Chapter 3: Nicotine Dependence Is Characterized by Disordered Reward Processing in a Network Driving Motivation - p. 84 80. Auditory P300 Event-Related Potentials and Neurocognitive Functions in Opioid Dependent Men and Their Brothers - p. 85 81. A Developmental Twin Study of Church Attendance and Alcohol and Nicotine Consumption: A Model for Analyzing the Changing Impact of Genes and Environment - p. 86 82. Are Women at Greater Risk? An Examination of Alcohol-Related Consequences and Gender - p. 87 83. Impact of Substance Use Disorders on Recovery From Episodes of Depression in Bipolar Disorder Patients: Prospective Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) - p. 88 84. Current alcohol use and risk for hypomania in male students: generally more or more binging? - p. 89 85. Acute Negative Affect Relief from Smoking Depends on the Affect Situation and Measure but Not on Nicotine - p. 90 86. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis - p. 91 87. Correlates of Self-Medication for Anxiety Disorders: Results From the National Epidemiolgic Survey on Alcohol and Related Conditions - p. 92 88. Alcohol Abstinence and Orthotopic Liver Transplantation in Alcoholic Liver Cirrhosis - p. 93 89. Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch - p. 94 90. Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained Patients: A Randomized, Double-blind, Placebo-Controlled Efficacy Trial - p. 95 91. A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol Dependence - p. 96 92. A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies - p. 97 93. From In-Session Behaviors to Drinking Outcomes: A Causal Chain for Motivational Interviewing - p. 98 94. Does Precontemplation Represent a Homogeneous Stage Category? A Latent Class Analysis on German Smokers - p. 99 95. Age at Regular Drinking, Clinical Course, and Heritability of Alcohol Dependence in the San Francisco Family Study: A Gender Analysis - p. 100 96. A genome-wide association study of alcohol dependence - p. 101 97. Chapter 4: Gender Differences in Chronic Medical, Psychiatric, and Substance-Dependence Disorders Among Jail Inmates - p. 102 98. Psychosocial Predictors of Military Misconduct - p. 103 99. General Medical Problems of Incarcerated Persons With Severe and Persistent Mental Illness: A Population-Based Study - p. 104 100. Impact of Intimate Partner Violence on Children's Well-Child Care and Medical Home - p. 105 101. Association between exposure to political violence and intimate-partner violence in the occupied Palestinian territory: a cross-sectional study - p. 106 102. Markers for Intimate Partner Violence in the Emergency Department Setting - p. 107 103. Mortality Risk Associated with Physical and Verbal Abuse in Women Aged 50 to 79 - p. 108 104. Partner Violence Before and After Couples-Based Alcoholism Treatment for Female Alcoholic Patients - p. 109 105. Reducing Maternal Intimate Partner Violence After the Birth of a Child: A Randomized Controlled Trial of the Hawaii Healthy Start Home Visitation Program - p. 110 106. A Randomized Clinical Trial of Multisystemic Therapy With Juvenile Sexual Offenders: Effects on Youth Social Ecology and Criminal Activity - p. 111 107. Confectionery consumption in childhood and adult violence - p. 112 108. Assessing Risk of Future Violence Among Forensic Psychiatric Inpatients With the Classification of Violence Risk (COVR) - p. 113 109. Criminal behaviour and violent crimes in former inpatients with affective disorder - p. 114 110. A National Study of Violent Behavior in Persons With Schizophrenia - p. 115 111. Legal Euthanasia in Belgium: Characteristics of All Reported Euthanasia Cases - p. 116 112. Bipolar disorder as a risk factor for repeat DUI behavior - p. 117 113. Dissipation and displacement of hotspots in reaction-diffusion models of crime - p. 118 114. Chapter 5: Geographic Patterns of Frequent Mental Distress: U.S. Adults, 1993–2001 and 2003–2006 - p. 119 115. Generational Status and Family Cohesion Effects on the Receipt of Mental Health Services Among Asian Americans: Findings From the National Latino and Asian American Study - p. 120 116. Mental Disorders Among Homeless People Admitted to a French Psychiatric Emergency Service - p. 121 117. Comparing Mental Health of Francophones in Canada, France, and Belgium: 12-Month and Lifetime Rates of Mental Health Service Use (Part 2) - p. 122 118. Adverse Childhood Experiences and the Risk of Premature Mortality - p. 123 119. Mortality Risk Associated with Physical and Verbal Abuse in Women Aged 50 to 79 - p. 124 120. State-Level Policies and Psychiatric Morbidity In Lesbian, Gay, and Bisexual Populations - p. 125 121. Economic impact of early intervention in people at high risk of psychosis - p. 126 122. Costs Associated With Changes in Antidepressant Treatment in a Managed Care Population With Major Depressive Disorder - p. 127 123. Health Status of People Undergoing Foreclosure in the Philadelphia Region - p. 128 124. The Long-Term Impact of Employment on Mental Health Service Use and Costs for Persons With Severe Mental Illness - p. 129 125. Financial Incentives and Accountability for Integrated Medical Care in Department of Veterans Affairs Mental Health Programs - p. 130 126. Black-skies planning? Prioritising mental health services in times of austerity - p. 131 127. Public Expenditures Related to the Criminal Justice System and to Services for Arrestees With a Serious Mental Illness - p. 132 128. Is Early Intervention in Psychosis Cost-Effective Over the Long Term? - p. 133 129. Early intervention in psychosis - p. 134 130. Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia - p. 135 131. The Influence of Past Unemployment Duration on Symptoms of Depression Among Young Women and Men in the United States - p. 136 132. Long-Term Mental Health Resource Utilization and Cost of Care Following Group Psychoeducation or Unstructured Group Support for Bipolar Disorders: A Cost-Benefit Analysis - p. 137 133. Dropout From Outpatient Mental Health Care in the United States - p. 138 134. A Delphi Study of Problems in Providing Community Care to Patients With Nonpsychotic Chronic Mental Illness - p. 139 135. Negative Attitudes Toward Help Seeking for Mental Illness in 2 Population–Based Surveys From the United States and Canada - p. 140 136. The Psychiatric Rehabilitation of African Americans With Severe Mental Illness - p. 141 137. The REACT Study: Cost-Effectiveness Analysis of Assertive Community Treatment in North London - p. 142 138. Cost, Effectiveness, and Cost-Effectiveness of a Collaborative Mental Health Care Program for People Receiving Short-Term Disability Benefits for Psychiatric Disorders - p. 143 139. Effectiveness and Outcomes of Assisted Outpatient Treatment in New York State - p. 144 140. A Randomized Trial of Medical Care Management for Community Mental Health Settings: The Primary Care Access, Referral, and Evaluation (PCARE) Study - p. 145 141. Provision of Mental Health Services in U.S. Nursing Homes, 1995–2004 - p. 146 142. Influence of perceived organisational factors on job burnout: survey of community mental health staff - p. 147 143. Burnout in Nonhospital Psychiatric Residential Facilities - p. 148 144. The Role of Patient Activation in Psychiatric Visits - p. 149 145. Assessment of Physical Illness by Mental Health Clinicians During Intake Visits - p. 150 146. Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care - p. 151 147. Toward Successful Postbooking Diversion: What Are the Next Steps? - p. 152 148. Oil and Water or Oil and Vinegar? Evidence-Based Medicine Meets Recovery - p. 153 149. Approval Ratings of Inpatient Coercive Interventions in a National Sample of Mental Health Service Users and Staff in England - p. 154 150. Coercion and Treatment Satisfaction Among Involuntary Patients - p. 155 151. Characteristics of Inpatients With a History of Recurrent Psychiatric Hospitalizations: A Matched-Control Study - p. 156 152. Weekend Prescribing Practices and Subsequent Seclusion and Restraint in a Psychiatric Inpatient Setting - p. 157 153. Factors Associated With Success of Smoke-Free Initiatives in Australian Psychiatric Inpatient Units - p. 158 154. The Influence of Neighborhood Environment on Treatment Continuity and Rehospitalization in Dually Diagnosed Patients Discharged From Acute Inpatient Care - p. 159 155. Severity of injury does not have any impact on posttraumatic stress symptoms in severely injured patients - p. 160 156. The Impact of Repression, Hostility, and Post-Traumatic Stress Disorder on All-Cause Mortality: A Prospective 16-Year Follow-up Study - p. 161 157. Injury-specific predictors of posttraumatic stress disorder - p. 162 158. A National US Study of Posttraumatic Stress Disorder, Depression, and Work and Functional Outcomes After Hospitalization for Traumatic Injury - p. 163 159. Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder - p. 164 160. Psychosocial buffers of traumatic stress, depressive symptoms, and psychosocial difficulties in veterans of Operations Enduring Freedom and Iraqi Freedom: The role of resilience, unit support, and postdeployment social support - p. 165 161. Trends and Risk Factors for Mental Health Diagnoses Among Iraq and Afghanistan Veterans Using Department of Veterans Affairs Health Care, 2002–2008 - p. 166 162. Battlemind Debriefing and Battlemind Training as Early Interventions With Soldiers Returning From Iraq: Randomization by Platoon - p. 167 163. Association Between Number of Deployments to Iraq and Mental Health Screening Outcomes in US Army Soldiers - p. 168 164. Deployment and the Use of Mental Health Services among U.S. Army Wives - p. 169 165. Persistence of Traumatic Memories in World War II Prisoners of War - p. 170 166. The Psychiatric Sequelae of Traumatic Injury - p. 171 167. Witnessing Trauma in the Newsroom: Posttraumatic Symptoms in Television Journalists Exposed to Violent News Clips - p. 172 168. Schizophrenia, Substance Abuse, and Violent Crime - p. 173 169. Posttraumatic Stress Disorder and Completed Suicide - p. 174 170. Mobile Crisis Team Intervention to Enhance Linkage of Discharged Suicidal Emergency Department Patients to Outpatient Psychiatric Services: A Randomized Controlled Trial - p. 175 171. Public attitudes towards people with mental illness in England and Scotland, 1994–2003 - p. 176 172. Jail Administrators' Perceptions of the Use of Psychiatric Advance Directives in Jails - p. 177 173. State Hospital-University Collaborations: A 25-Year Follow-Up - p. 178 174. Chapter 6: Comorbid Depression Is Associated with an Increased Risk of Dementia Diagnosis in Patients with Diabetes: A Prospective Cohort Study - p. 179 175. Early adversity and 5-HTT/BDNF genes: new evidence of gene–environment interactions on depressive symptoms in a general population - p. 180 176. A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD) - p. 181 177. A Randomized, Double-Blind, Placebo-Controlled Study of Testosterone Treatment in Hypogonadal Older Men With Subthreshold Depression (Dysthymia or Minor Depression) - p. 182 178. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication - p. 183 179. Volumetric MRI study of the insular cortex in individuals with current and past major depression - p. 184 180. Family Problems Among Recently Returned Military Veterans Referred for a Mental Health Evaluation - p. 185 181. An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression - p. 186 182. A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression - p. 187 183. Illness Risk Following Rapid Versus Gradual Discontinuation of Antidepressants - p. 188 184. Interaction between genetic polymorphisms and stressful life events in first episode depression - p. 189 185. Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression - p. 190 186. Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies - p. 191 187. Depression and Advanced Complications of Diabetes: A prospective cohort study - p. 192 188. Effects of Estradiol on Learned Helplessness and Associated Remodeling of Hippocampal Spine Synapses in Female Rats - p. 193 189. A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes - p. 194 190. Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials - p. 195 191. A Randomized Controlled Trial Comparing the Memory Effects of Continuation Electroconvulsive Therapy Versus Continuation Pharmacotherapy: Results From the Consortium for Research in ECT (CORE) Study - p. 196 192. Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline - p. 197 193. Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study - p. 198 194. Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients - p. 199 195. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects - p. 200 196. Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression - p. 201 197. Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: Replication and extension in the Swiss health care system - p. 202 198. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients - p. 203 199. Disturbances in early parenting of depressed mothers and cortisol secretion in offspring: A preliminary study - p. 204 200. Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns? - p. 205 201. Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report - p. 206 202. Effects of the Serotonin 1A, 2A, 2C, 3A, and 3B and Serotonin Transporter Gene Polymorphisms on the Occurrence of Paroxetine Discontinuation Syndrome - p. 207 203. Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes - p. 208 204. Transcranial direct current stimulation in severe, drug-resistant major depression - p. 209 205. A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: A pilot randomised controlled trial - p. 210 206. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments - p. 211 207. Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies - p. 212 208. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression - p. 213 209. Early stages in the development of bipolar disorder - p. 214 210. Antidepressant Discontinuation in Bipolar Depression: A Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Randomized Clinical Trial of Long-Term Effectiveness and Safety - p. 215 211. A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II) - p. 216 212. Olanzapine vs. lithium in management of acute mania - p. 217 213. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review - p. 218 214. A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I) - p. 219 215. Association between consistent purchase of anticonvulsants or lithium and suicide risk: A longitudinal cohort study from Denmark, 1995–2001 - p. 220 216. A comparison of life events in patients with unipolar disorder or bipolar disorder and controls - p. 221 217. Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report - p. 222 218. Sleep, illness course, and concurrent symptoms in inter-episode bipolar disorder - p. 223 219. Response to ECT in bipolar I, bipolar II and unipolar depression - p. 224 220. Suicide Attempts, Gender, and Sexual Abuse: Data From the 2000 British Psychiatric Morbidity Survey - p. 225 221. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy - p. 226 222. Reducing Suicidal Ideation and Depression in Older Primary Care Patients: 24-Month Outcomes of the PROSPECT Study - p. 227 223. Panic disorder as a risk factor for post-partum depression: Results from the Perinatal Depression-Research & Screening Unit (PND-ReScU) study - p. 228 224. Dimensional predictors of response to SRI pharmacotherapy in obsessive–compulsive disorder - p. 229 225. Early Temperament Prospectively Predicts Anxiety in Later Childhood - p. 230 226. Diagnosis of multiple anxiety disorders predicts the concurrent comorbidity of major depressive disorder - p. 231 227. Deep Brain Stimulation for Intractable Obsessive Compulsive Disorder: Pilot Study Using a Blinded, Staggered-Onset Design - p. 232 228. Association of Poor Childhood Fear Conditioning and Adult Crime - p. 233 229. An Increased Risk of Stroke Among Panic Disorder Patients: A 3–Year Follow–up Study - p. 234 230. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) - p. 235 231. Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine - p. 236 232. Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia? - p. 237 233. A Comparison Study of Multiple Measures of Adherence to Antipsychotic Medication in First-Episode Psychosis - p. 238 234. A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia - p. 239 235. Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST) - p. 240 236. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study - p. 241 237. A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone - p. 242 238. Does Clozapine Promote Employability and Reduce Offending Among Mentally Disordered Offenders? - p. 243 239. Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks - p. 244 240. Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men - p. 245 241. Which Physician and Practice Characteristics are Associated With Adherence to Evidence-Based Guidelines for Depressive and Anxiety Disorders? - p. 246 242. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study - p. 247 243. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: An 18-month naturalistic follow-up - p. 248 244. Adult Outcomes of Youth Irritability: A 20-year Prospective Community-Based Study - p. 249 245. Did Medicare Part D Improve Access to Medications? - p. 250 246. Does the judicious use of safety behaviors improve the efficacy and acceptability of exposure therapy for claustrophic fear? - p. 251 247. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling - p. 252 248. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone - p. 253 249. Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial - p. 254 250. Consequences of Receipt of a Psychiatric Diagnosis for Completion of College - p. 255 251. Association of Western and Traditional Diets With Depression and Anxiety in Women - p. 256 252. Dizziness, migrainous vertigo and psychiatric disorders - p. 257 253. State anxiety and subjective well-being responses to acute bouts of aerobic exercise in patients with depressive and anxiety disorders - p. 258 254. A Randomized, Double-Blind, Placebo-Controlled Trial of St John's Wort for Treating Irritable Bowel Syndrome - p. 259 255. Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents - p. 260 256. Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine: A Crossover Study - p. 261 257. Americans' Attitudes Toward Psychiatric Medications: 1998–2006 - p. 262 258. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial - p. 263 259. Comparison of Topiramate and Risperidone for the Treatment of Behavioral Disturbances of Patients With Alzheimer Disease: A Double-Blind, Randomized Clinical Trial - p. 264 260. Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation - p. 265 261. Novelty seeking among adult women is lower for the winter borns compared to the summer borns: replication in a large Finnish birth cohort - p. 266 262. Acute Psychological Stress Reduces Working Memory-Related Activity in the Dorsolateral Prefrontal Cortex - p. 267 263. Distinctiveness of psychological obstacles to recovery in low back pain patients in primary care - p. 268 264. Prevalence and comorbidity of common mental disorders in primary care - p. 269 265. Chapter 7: Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study - p. 270 266. Dizziness, migrainous vertigo and psychiatric disorders - p. 271 267. Olanzapine vs. lithium in management of acute mania - p. 272 268. Transient Estradiol Exposure during Middle Age in Ovariectomized Rats Exerts Lasting Effects on Cognitive Function and the Hippocampus - p. 273 269. Subjective Experience of Cognitive Failures as Possible Risk Factor for Negative Symptoms of Psychosis in the General Population - p. 274 270. Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis - p. 275 271. Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study - p. 276 272. Auditory Hallucinations in Dissociative Identity Disorder and Schizophrenia With and Without a Childhood Trauma History: Similarities and Differences - p. 277 273. Misattributions of agency in schizophrenia are based on imprecise predictions about the sensory consequences of one's actions - p. 278 274. Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-D-Aspartate Antagonist - p. 280 275. A Cross-Sectional Evaluation of the Effect of Risperidone and Selective Serotonin Reuptake Inhibitors on Bone Mineral Density in Boys - p. 281 276. Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders - p. 282 277. Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 1 - p. 283 278. A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression - p. 284 279. Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study - p. 285 280. Serotonin Transporter Gene Promoter Polymorphism and Somatoform Symptoms - p. 286 281. Gender Differences in Risk Factors for Aberrant Prescription Opioid Use - p. 287 282. Comparative genomics of autism and schizophrenia - p. 288 283. Altered gene expression in neural crest cells exposed to ethanol in vitro - p. 289 284. Copy Number Variation in Schizophrenia in the Japanese Population - p. 290 285. Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects - p. 291 286. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression - p. 292 287. Brain-Derived Neurotrophic Factor Signaling Modulates Cocaine Induction of Reward-Associated Ultrasonic Vocalization in Rats - p. 293 288. Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression - p. 294 289. Brain-derived neurotrophic factor and cocaine addiction - p. 295 290. Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder - p. 296 291. Green tea consumption is associated with depressive symptoms in the elderly - p. 297 292. The involuntary nature of conversion disorder - p. 298 293. Neuroinflammation in Alzheimer's Disease and Major Depression - p. 299 294. Physical and psychosocial functioning following motor vehicle trauma: Relationships with chronic pain, posttraumatic stress, and medication use - p. 300 295. Fluoxetine Potentiates Methylphenidate-Induced Gene Regulation in Addiction-Related Brain Regions: Concerns for Use of Cognitive Enhancers? - p. 301 296. Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models - p. 302 297. Treatment response in major depression: effects of personality dysfunction and prior depression - p. 303 298. A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder - p. 304 299. Sharing and Selling of Prescription Medications in a College Student Sample - p. 305 300. Disrupting the prefrontal cortex diminishes the human ability to build a good reputation - p. 306 301. Are Gold Standard Depression Measures Appropriate for Use in Geriatric Cancer Patients? A Systematic Evaluation of Self-Report Depression Instruments Used With Geriatric, Cancer, and Geriatric Cancer Samples - p. 307 302. Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting - p. 308